000			01956 a2200529 4500
005			20250516153131.0
264		0	_c20131126
008			201311s 0 0 eng d
022			_a1471-2407
024	7		_a10.1186/1471-2407-13-273 _2doi
040			_aNLM _beng _cNLM
100	1		_aKumar, B N Prashanth
245	0	0	_aCelecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. _h[electronic resource]
260			_bBMC cancer _cJun 2013
300			_a273 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aAutocrine Communication _xdrug effects
650	0	4	_aBlotting, Western
650	0	4	_aBreast Neoplasms _xmetabolism
650	0	4	_aCelecoxib
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aNeovascularization, Pathologic _xchemically induced
650	0	4	_aPyrazoles _xadministration & dosage
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xmetabolism
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSulfonamides _xadministration & dosage
650	0	4	_aTamoxifen _xadministration & dosage
650	0	4	_aTransfection
650	0	4	_aVascular Endothelial Growth Factor A _xmetabolism
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aRajput, Shashi
700	1		_aDey, Kaushik Kumar
700	1		_aParekh, Aditya
700	1		_aDas, Subhasis
700	1		_aMazumdar, Abhijit
700	1		_aMandal, Mahitosh
773	0		_tBMC cancer _gvol. 13 _gp. 273
856	4	0	_uhttps://doi.org/10.1186/1471-2407-13-273 _zAvailable from publisher's website
999			_c22803455 _d22803455